SG Americas Securities LLC decreased its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 72.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,120 shares of the technology company’s stock after selling 24,271 shares during the quarter. SG Americas Securities LLC’s holdings in Veeva Systems were worth $2,717,000 as of its most recent filing with the SEC.
A number of other large investors also recently modified their holdings of the business. HB Wealth Management LLC lifted its holdings in Veeva Systems by 5.2% in the third quarter. HB Wealth Management LLC now owns 19,382 shares of the technology company’s stock worth $5,774,000 after purchasing an additional 958 shares during the period. Spire Wealth Management raised its position in shares of Veeva Systems by 7,006.4% during the 3rd quarter. Spire Wealth Management now owns 20,964 shares of the technology company’s stock worth $6,245,000 after buying an additional 20,669 shares in the last quarter. KLP Kapitalforvaltning AS lifted its stake in shares of Veeva Systems by 0.3% in the 3rd quarter. KLP Kapitalforvaltning AS now owns 57,800 shares of the technology company’s stock worth $17,219,000 after acquiring an additional 200 shares during the period. Cerity Partners LLC lifted its stake in shares of Veeva Systems by 29.4% in the 3rd quarter. Cerity Partners LLC now owns 132,624 shares of the technology company’s stock worth $39,510,000 after acquiring an additional 30,093 shares during the period. Finally, CoreCap Advisors LLC boosted its holdings in shares of Veeva Systems by 257.3% in the third quarter. CoreCap Advisors LLC now owns 1,297 shares of the technology company’s stock valued at $386,000 after acquiring an additional 934 shares in the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.
Veeva Systems Stock Down 2.0%
Shares of NYSE VEEV opened at $228.47 on Wednesday. Veeva Systems Inc. has a 52-week low of $201.54 and a 52-week high of $310.50. The stock has a market capitalization of $37.56 billion, a price-to-earnings ratio of 44.45, a PEG ratio of 1.72 and a beta of 1.07. The stock’s fifty day simple moving average is $244.46 and its 200 day simple moving average is $270.25.
Veeva Systems announced that its board has initiated a share buyback plan on Monday, January 5th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the technology company to reacquire up to 5.5% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.
Analyst Ratings Changes
VEEV has been the topic of several recent analyst reports. Weiss Ratings cut Veeva Systems from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday. Needham & Company LLC reiterated a “buy” rating and set a $355.00 price target on shares of Veeva Systems in a research report on Friday, November 21st. BMO Capital Markets initiated coverage on Veeva Systems in a research note on Thursday, November 13th. They issued a “market perform” rating and a $300.00 price objective on the stock. TD Cowen raised Veeva Systems from a “hold” rating to a “buy” rating and raised their target price for the company from $297.00 to $380.00 in a research note on Tuesday, October 7th. Finally, Citigroup lowered their target price on Veeva Systems from $349.00 to $319.00 and set a “buy” rating on the stock in a report on Monday, November 24th. Eighteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Veeva Systems presently has an average rating of “Moderate Buy” and a consensus target price of $308.04.
Check Out Our Latest Stock Analysis on VEEV
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Read More
- Five stocks we like better than Veeva Systems
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Ominous day” coming to stocks…
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
